WHICH FORM OF THIAMINE
The form of thiamine which has been used in the original B1 protocol for the oral and intramuscular routes is thiamine HCL (hydrochloride) (Luong, 2012; Costantini, 2013, 2015, 2018).
Selected references
Khanh vinh quoc Luong, Lan Thi Hoang Nguyen, The Beneficial Role of Thiamine in Parkinson’s Disease: Preliminary Report, J Neurol Res. 2012, 2 (5):211-214
Costantini, MI Pala, L. Compagnoni, M. Colangeli, High-dose thiamine as initial treatment for Parkinson's disease, BMJ Case Rep 2013 Aug 28, ii: bcr2013009289.
A. Costantini, MI Pala, E. Grossi, S. Mondonico, L. Ercoli Cardelli, C. Jenner, S. Proietti, M. Colangeli, Roberto Fancellu, Long-Term Treatment with High-Dose Thiamine in Parkinson Disease: An Open-Label Pilot Study, J Altern Complement Med. 2015 Dec;21(12):740-7
Costantini and R. Fancellu, Effects of Overdose of High-Dose Thiamine Treatment, Gerontology & Geriatrics Studies, December 06, 2018
Dr Costantini’s website on High-dose Thiamine (HDT) Therapy for Parkinson’s Disease, Accessed 28.02.2023
Text author: Sergio Pièche
Page updated - 24/04/23
Page updated - 24/04/23